Archives

Shields Health Solutions and Lakeland Regional Health Collaborate to Enhance Patient Access to Specialty Pharmacy Care 1024 1024 Shields Health Solutions

Shields Health Solutions and Lakeland Regional Health Collaborate to Enhance Patient Access to Specialty Pharmacy Care

The partnership will support patients through personalized care, medications, and coordinationShields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country, has partnered with Lakeland Regional Health, one of…

Helping Patients Take Control: How Pharmacists Empower Diabetes Management 150 150 Shields Health Solutions

Helping Patients Take Control: How Pharmacists Empower Diabetes Management

Pharmacists play a vital and growing role in managing diabetes care. By collaborating with healthcare providers and patients, pharmacists ensure safe, effective care in settings such as on-site clinics and…

Revenue and Patient Volume Associated with Accreditation Restricted Limited Distribution Drugs in Health System Specialty Pharmacies 216 115 Shields Health Solutions

Revenue and Patient Volume Associated with Accreditation Restricted Limited Distribution Drugs in Health System Specialty Pharmacies

    Accreditation positions health system specialty pharmacies to expand access to high-value medications and supports integrated caremodels shown to reduce healthcare costs.  

Ambulatory Clinical Pharmacist Impact on Coverage Determinations for Specialty Oncology Medications 216 115 Shields Health Solutions

Ambulatory Clinical Pharmacist Impact on Coverage Determinations for Specialty Oncology Medications

    This poster evaluates the impact of an ambulatory clinical pharmacist (ACP) program on third party pharmacy coverage determinationoutcomes for specialty oncology medications prescribed from these clinics.  

Evaluating Health System Time Demands and Challenges of Specialty Pharmacy Accreditation 216 115 Shields Health Solutions

Evaluating Health System Time Demands and Challenges of Specialty Pharmacy Accreditation

    This poster evaluate the challenges, time commitments, and resource allocation associated withachieving and maintaining SP accreditation among health-system specialty pharmacies.  

Analysis of Oral Oncolytic Waste for Patients Filling at a Health System Specialty Pharmacy 216 115 Shields Health Solutions

Analysis of Oral Oncolytic Waste for Patients Filling at a Health System Specialty Pharmacy

  This poster evaluates existing oral oncology medication waste events among patients filling at a health system specialty pharmacy (HSSP).  

Treatment Utilization Patterns and Time To Therapy Discontinuation in Patients with ALK+ Metastatic Non-Small Cell Lung Cancer 216 115 Shields Health Solutions

Treatment Utilization Patterns and Time To Therapy Discontinuation in Patients with ALK+ Metastatic Non-Small Cell Lung Cancer

    This poster explores treatment utilization patterns and time to discontinuation (TTD) in patients receiving ALK TKIs for ALK+ mNSCLC.  

Clinical and Quality Outcomes of a Bleeding Disorder Program in a Health System Specialty Pharmacy 216 115 Shields Health Solutions

Clinical and Quality Outcomes of a Bleeding Disorder Program in a Health System Specialty Pharmacy

 This poster evaluates the clinical and quality outcomes of a bleeding disorder program in a health system specialty pharmacy.  

The Impact of Re-Training Specialty Pharmacy Outreach Technicians and Optimizing Compliance and Productivity 216 115 Shields Health Solutions

The Impact of Re-Training Specialty Pharmacy Outreach Technicians and Optimizing Compliance and Productivity

  This poster assesses the impact of re-training for specialty pharmacy outreach technicians by evaluating improvements in compliance knowledge, technician productivity, and patient enrollment rates.  

Clinical, Safety, and Quality Outcomes of a Hypertrophic Cardiomyopathy Clinical Pharmacy Management Program 216 115 Shields Health Solutions

Clinical, Safety, and Quality Outcomes of a Hypertrophic Cardiomyopathy Clinical Pharmacy Management Program

  This poster evaluates the clinical, safety, and quality outcomes of a pharmacist-led hypertrophic cardiomyopathy (HCM) clinical management program.